| Drug-induced liver injury from antituberculous treatment: a retrospective study from a large TB centre in the UK A Abbara, S Chitty, JK Roe, R Ghani, SM Collin, A Ritchie, OM Kon, ... BMC Infectious Diseases 17, 1-9, 2017 | 140 | 2017 |
| Disease prevention not decolonization: a model for fecal microbiota transplantation in patients colonized with multidrug-resistant organisms R Ghani, BH Mullish, JAK McDonald, A Ghazy, HRT Williams, ... Clinical Infectious Diseases 72 (8), 1444-1447, 2021 | 56 | 2021 |
| The potential utility of fecal (or intestinal) microbiota transplantation in controlling infectious diseases R Ghani, BH Mullish, LA Roberts, FJ Davies, JR Marchesi Gut Microbes 14 (1), 2038856, 2022 | 27 | 2022 |
| Fecal microbiota transplant mitigates adverse outcomes seen in patients colonized with multidrug-resistant organisms undergoing allogeneic hematopoietic cell transplantation AJ Innes, BH Mullish, R Ghani, RM Szydlo, JF Apperley, E Olavarria, ... Frontiers in Cellular and Infection Microbiology 11, 684659, 2021 | 22 | 2021 |
| Antibiotics promote intestinal growth of carbapenem-resistant Enterobacteriaceae by enriching nutrients and depleting microbial metabolites AYG Yip, OG King, O Omelchenko, S Kurkimat, V Horrocks, P Mostyn, ... Nature Communications 14 (1), 5094, 2023 | 12 | 2023 |
| The potential of fecal microbiota transplantation in oncology MP Lythgoe, R Ghani, BH Mullish, JR Marchesi, J Krell Trends in Microbiology 30 (1), 10-12, 2022 | 9 | 2022 |
| How to Adapt an Intestinal Microbiota Transplantation program to reduce the risk of invasive multidrug-resistant infection R Ghani, BH Mullish, FJ Davies, JR Marchesi Clinical Microbiology and Infection, 2021 | 9 | 2021 |
| Severe disseminated infection with emerging lineage of methicillin-sensitive Staphylococcus aureus P Jewell, L Dixon, A Singanayagam, R Ghani, E Wong, M Coleman, ... Emerging Infectious Diseases 25 (1), 187, 2019 | 5 | 2019 |
| Faecal microbiota transplant for eradication of multidrug-resistant Enterobacteriaceae: a lesson in applying best practice? Re:‘A five-day course of oral antibiotics followed … BH Mullish, R Ghani, JAK McDonald, JR Marchesi Clinical Microbiology and Infection 25 (7), 912-913, 2019 | 4 | 2019 |
| Clinical risk stratification and antibiotic management of NDM and OXA-48 carbapenemase-producing Enterobacteriaceae bloodstream infections in the UK DK Ming, JA Otter, R Ghani, ET Brannigan, A Boonyasiri, S Mookerjee, ... The Journal of hospital infection 102 (1), 95-97, 2019 | 3 | 2019 |
| Recurrent tuberculosis at a large tuberculosis Centre in the UK K Avery, A Abbara, R Ghani, RN Davidson Journal of Infection 70 (4), 427-429, 2015 | 3 | 2015 |
| Bone and Joint Infections J Dave, R Ghani Tutorial Topics in Infection for the Combined Infection Training Programme, 2015 | 2 | 2015 |
| Reply to Woodworth, et al. BH Mullish, R Ghani, JAK McDonald, F Davies, JR Marchesi Clinical Infectious Diseases 72 (11), e924-e925, 2021 | 1 | 2021 |
| 1144 FECAL MICROBIOTA TRANSPLANT FOR MULTI-DRUG RESISTANT ORGANISMS: IMPROVED CLINICAL OUTCOMES BEYOND INTESTINAL DECOLONISATION R Ghani, BH Mullish, JA McDonald, A Ghazy, HR Williams, E Brannigan, ... Gastroenterology 158 (6), S-227-S-228, 2020 | 1 | 2020 |
| M41 recurrent tuberculosis and its risk factors in the UK’s largest TB centre K Avery, R Ghani, J Buckley, L John, RN Davidson Thorax 69 (Suppl 2), A210-A211, 2014 | 1 | 2014 |
| Reversing the tide of the UK tuberculosis epidemic N Shah, S Young, R Ghani, L John, RN Davidson tuberculosis 3, 5, 2014 | 1 | 2014 |
| Decision: Considerations for Use of Fecal Microbiota Transplantation in Special Patient Populations R Ghani, BH Mullish The 6 Ds of Fecal Microbiota Transplantation, 43-53, 2024 | | 2024 |
| 894: RELATIVE CHANGE OF ENTEROCOCCUS FAECIUM, SELECTED COMMENSAL BACTERIA AND CYTOKINES ARE SEEN IN PATIENTS COLONIZED WITH MULTIDRUG-RESISTANT ORGANISMS WHO UNDERGO INTESTINAL … R Ghani, JM Blanco, R Forlano, E Triantafyllou, J Bilinski, ... Gastroenterology 162 (7), S-218-S-219, 2022 | | 2022 |
| 811 FECAL MICROBIOTA TRANSPLANT PRIOR TO ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT IN PATIENTS COLONIZED WITH MULTI-DRUG RESISTANT ORGANISMS IS ASSOCIATED WITH IMPROVED SURVIVAL BH Mullish, AJ Innes, R Ghani, R Szydlo, HR Williams, MR Thursz, ... Gastroenterology 160 (6), S-168-S-169, 2021 | | 2021 |
| Faecal Microbiota Transplant (FMT) Can Reduce The High NRM Associated with Multi-Drug Resistant Organism (MDRO) Colonisation Prior to Allogeneic HCT AJ Innes, R Ghani, BH Mullish, R Szydlo, E Brannigan, R Palanicawandar, ... BONE MARROW TRANSPLANTATION 55 (SUPPL 1), 112-112, 2020 | | 2020 |
